期刊文献+

子宫内膜癌Ⅳb期临床特征和预后分析

Treatment and prognostic of stage Ⅳb of endometrial carcinoma
暂未订购
导出
摘要 目的:分析Ⅳb期子宫内膜癌的临床特征,探讨与其预后的相关因素。方法:回顾性分析Ⅳb期子宫内膜癌的临床病理特征及随访结果。结果: 11例子宫内膜癌Ⅳb期患者,平均 61. 1岁,绝经 9例,平均绝经 14.9年。临床症状主要是绝经后阴道不规则出血或血性分泌物(9/11),其次为腹胀(4/11)、腹部包块(3/11),出现症状至就诊平均 15.1个月。 10例手术治疗, 1例拒绝手术,仅行内分泌治疗,8例行术中、术后化疗,3例术后放疗;平均随访 12.9个月,死亡 6例,2年生存率 28%,3年生存率 14%。盆腹腔复发 3例均死亡,平均存活 6.7个月,发生肺转移5例,3例死亡,平均存活14.7个月。术后残存病灶>2cm 4例,均因复发转移死亡,平均存活9个月,术后无残存病灶3例均存活。结论:Ⅳb期子宫内膜癌患者年龄较大,就诊较晚,多表现为绝经后不规则阴道出血,治疗以手术为主,尽可能切除所有病灶,并辅助放化疗,但预后较差,其相关因素主要有首次手术的彻底性,宫旁血管淋巴管受侵,病灶范围及复发转移部位等。 Objecthe: To analyze the clinicopathologic characteristics and prognostic factors of stage endometrial carcinoma. Methods: The clinical appearances, pathologic features, status of treatment and follow - up of 11 patients of endometrial carcinoma(stage Ⅳb)were analyzed retrospectively. Results: 11 patients, avarage age 61. 1 years,postmeno- pause 9 cases. The common symptoms of these patients were the vaginal irregular bleeding (9/11 ), abdominal distension(4/1), abdominal mass(3/11) and ascites(3/11). The median time interval from appearing symptom to diagnosis was 15. 1 months. 10 patients were operat- ed, and 8 patients received chemotherapy intra- or post - operation, 3 patients received ra- diation. All patients were followed - up 12.9 months (5 - 30months), and 6 cases died, 3 cases recurred in pelvic and abdominal cavity, 5 cases metastasized to lung. Survival rates of 2 - years and 3 - years were 28 .0%, 14.0% respectively.Conclusions:The prognosis of stage IVb endometrial carcinoma was very poor. The related factors of prognosis were opti- mal cytoreduction , the site of recurrence and metastasis, and lymph vescular invasion.
出处 《现代妇产科进展》 CSCD 2000年第6期412-415,共4页 Progress in Obstetrics and Gynecology
关键词 子宫内膜肿瘤 预后 外科手术 妇科 Endometrial neoplasms Prognosis Surgery gynecology
  • 相关文献

参考文献8

  • 1ParkerSL,TongT,BoldenS,etal.Cancerstatics.CancerJClin,47:5-27
  • 2GoffBA,GoodmanA,HuntzHG,etal.SurgicalstageⅣendometrialcarcinoma:Astudyof47cases.GynecolOncol,1994,52:237-140
  • 3ChiDS,WelshigerM,VenkatanmES.etal.TheroleofsurgicalcytoreductiveinstageⅣendometrialcarcinona.GynecolOncol,1997,67:56-60
  • 4GreerBE,HamnergerAD.Treatmentofinraperitonealmetastaticadenocarcinomaoftheendometriumthewholeadbomenmovingstriptechniqueandpelvicboostirradiation.GynecolOncol,1983,16:365-373
  • 5魏丽惠 钱和年 吴燕 等.氩气束凝固器在卵巢癌手术中的应用[J].北京医科大学学报,1995,27:201-201.
  • 6MarkmanM,KennedyA,WedsterK,etal.Persistentchemosensivitytoplatinumand/orpaclitaxelinmatastaicendometrialcancer.GvnecolOncol,1999,73:422-423
  • 7RandallME,ReisingerS.Radiationtherapyandcombinedwithchemotherapy,irradiationinadvancedandrecurrencedendometrialcarcinoma.SemiOncol,1994,21:99
  • 8FeltmateCM,DusksLR,ChangYC,etal.PredictorsdrecurrenceinsurgicalstageⅡendometrialadenocarcinorma.GynecolOncol,1999,73:407-411

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部